Validated RP-HPLC method for the simultaneous analysis of gemcitabine and LY-364947 in liposomal formulations

Keyphrases

• A1 Receptor 14%
• Accuracy Limits 14%
• Ammonium Phosphate 14%
• C18 Column 14%
• Co-encapsulation 14%
• Co-loaded Liposomes 14%
• Collagen Production 14%
• Drug Penetration 14%
• Encapsulation Efficiency 14%
• Fetal Bovine Serum 28%
• Formulation Characterization 14%
• Gemcitabine 100%
• Limit of Detection 14%
• Liposomal 14%
• Liposomal Encapsulation 14%
• Liposomal Formulation 100%
• Liposomes 42%
• Methanol 14%
• Method Sensitivity 14%
• Method Validation 14%
• Mobile Phase 14%
• Pancreatic Cancer 14%
• Pharmacokinetic Analysis 14%
• Precision Accuracy 14%
• Receptor Antagonist 14%
• Retention Time 14%
• Reversed-phase HPLC 14%
• RP-HPLC Method 100%
• Simultaneous Analysis 100%
• Simultaneous Detection 14%
• Simultaneous Quantification 14%
• TGF-1 14%
• Tumor Drugs 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Gemcitabine 100%
• High Performance Liquid Chromatography 100%
• Liposome 57%
• Methanol 14%
• Neoplasm 14%
• Pancreas Cancer 14%
• Pharmacokinetic 14%
• Receptor 14%
• Reverse Phase High Performance Liquid Chromatography 100%

Biochemistry, Genetics and Molecular Biology

• Drug Penetration 14%
• Gemcitabine 100%
• High-Performance Liquid Chromatography 100%
• Pharmacokinetic 14%
• Retention Time 14%